
Precision medicine and engineering., Год журнала: 2024, Номер unknown, С. 100013 - 100013
Опубликована: Ноя. 1, 2024
Язык: Английский
Precision medicine and engineering., Год журнала: 2024, Номер unknown, С. 100013 - 100013
Опубликована: Ноя. 1, 2024
Язык: Английский
Aging and Disease, Год журнала: 2025, Номер unknown, С. 0 - 0
Опубликована: Янв. 1, 2025
Nanozymes, which are nanomaterials that replicate the catalytic activities of natural enzymes in biological systems, have recently demonstrated considerable potential improving cancer immunotherapy by altering tumor microenvironment. Nanozyme-driven immune responses represent an innovative therapeutic modality with high effectiveness and minimal side effects. These nanozymes activate system to specifically recognize destroy cells. Combined immunotherapeutic agents, can amplify anti-cancer integrating remodeling immunogenic cell death (ICD). This review offers a thorough discussion about various involved immunity, including those mimicking catalase (CAT), superoxide dismutase (SOD), peroxidase (POD), oxidase (OXD). It also discusses challenges future directions for translating nanozyme platforms into clinical applications, enhancing susceptibility cells immunotherapy. Nanozyme-based strategies substantial oncology, offering new effective options management.
Язык: Английский
Процитировано
0ACS Applied Nano Materials, Год журнала: 2025, Номер unknown
Опубликована: Апрель 8, 2025
Язык: Английский
Процитировано
0Precision medicine and engineering., Год журнала: 2024, Номер unknown, С. 100013 - 100013
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
2